drugset / Trial / NCT02614482
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long term tolerability of Fesoterodine and its efficacy for overactive bladder syndrome in children.
Timeline
- Start
- 2015-10
- Primary completion
- 2018-06
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | Oral |
| Subject | Fesoterodine | Other / unclassified | 8 mg | Oral |